Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Venous Thromboembolism

  • News

    Prophylactic anticoagulation tied to lower death rate in COVID

    June 18, 2021

    Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.

  • News

    Factor XI inhibitor–based anticoagulation strategies gain ground

    November 18, 2020

    “When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”

  • 1
    News

    HOME-PE trial clarifies which pulmonary embolism patients to treat at home

    September 1, 2020

    “Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides

  • 1
    News

    PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis

    April 21, 2020

    Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and reduced rates of VTE and aortic stenosis.

  • 1
    News

    New ASH guideline: VTE prophylaxis after major surgery

    December 12, 2019

    ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.

  • 1
    News

    Smokers with PE have higher rate of hospital readmission

    November 11, 2019

    NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco dependence.

  • 1
    News

    FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients

    October 15, 2019

    The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.

  • 1
    News

    Older IBD patients are most at risk of postdischarge VTE

    September 10, 2019

    Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.

  • 1
    News

    No reduction in PE risk with vena cava filters after severe injury

    July 9, 2019

    MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in patients who can be treated with prophylactic anticoagulation within 7 days after injury,” the investigators wrote.

  • 1
    News

    Rivaroxaban tied to higher GI bleeding than other NOACs

    June 17, 2019

    SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.

Previous1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences